Acasti Pharma Retained Earnings (Accumulated Deficit) 2014-2024 | GRCE

Acasti Pharma retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.

Acasti Pharma Retained Earnings (Accumulated Deficit) 2014-2024 | GRCE

Acasti Pharma retained earnings (accumulated deficit) from 2014 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Related Stocks
Company NameMarket
Cap
Merck (MKKGY)$21.3B
New York Community Bancorp (FLG)$4.3B